메뉴 건너뛰기




Volumn 38, Issue 4, 2003, Pages 547-554

Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; ANTIBODY; QS 21;

EID: 0038100154     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00294-0     Document Type: Article
Times cited : (739)

References (44)
  • 1
    • 0033835996 scopus 로고    scopus 로고
    • Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
    • Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K.et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6:2000;916-919.
    • (2000) Nat. Med. , vol.6 , pp. 916-919
    • Bard, F.1    Cannon, C.2    Barbour, R.3    Burke, R.L.4    Games, D.5    Grajeda, H.6    Guido, T.7    Hu, K.8    Huang, J.9    Johnson-Wood, K.10
  • 4
    • 0036828769 scopus 로고    scopus 로고
    • Alzheimer's disease: Treatments in discovery and development
    • Citron M. Alzheimer's disease. treatments in discovery and development Nat. Neurosci. 5:2002;1055-1057.
    • (2002) Nat. Neurosci. , vol.5 , pp. 1055-1057
    • Citron, M.1
  • 5
    • 0035902619 scopus 로고    scopus 로고
    • Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
    • DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.C., Paul S.M., Holtzman D.M. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 98:2001;8850-8855.
    • (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 8850-8855
    • DeMattos, R.B.1    Bales, K.R.2    Cummins, D.J.3    Dodart, J.C.4    Paul, S.M.5    Holtzman, D.M.6
  • 6
    • 0037155581 scopus 로고    scopus 로고
    • Brain to plasma amyloid-β efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease
    • DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-β efflux. a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science. 295:2002;2264-2267.
    • (2002) Science , vol.295 , pp. 2264-2267
    • DeMattos, R.B.1    Bales, K.R.2    Cummins, D.J.3    Paul, S.M.4    Holtzman, D.M.5
  • 8
    • 0036639707 scopus 로고    scopus 로고
    • Novel strategies provide the real test for the amyloid hypothesis of Alzheimer's disease
    • Dominguez D.I., De Strooper B. Novel strategies provide the real test for the amyloid hypothesis of Alzheimer's disease. Trends Pharmacol. Sci. 23:2002;324-330.
    • (2002) Trends Pharmacol. Sci. , vol.23 , pp. 324-330
    • Dominguez, D.I.1    De Strooper, B.2
  • 9
    • 0035103036 scopus 로고    scopus 로고
    • Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
    • Doody R.S., Geldmacher D.S., Gordon B., Perdomo C.A., Pratt R.D. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch. Neurol. 58:2001;427-433.
    • (2001) Arch. Neurol. , vol.58 , pp. 427-433
    • Doody, R.S.1    Geldmacher, D.S.2    Gordon, B.3    Perdomo, C.A.4    Pratt, R.D.5
  • 10
    • 0016823810 scopus 로고
    • "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
    • Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
    • (1975) J. Psychiatr. Res. , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 11
    • 0036860342 scopus 로고    scopus 로고
    • Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease
    • Gandy S. Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease. Neurobiol. Aging. 23:2002;1009-1016.
    • (2002) Neurobiol. Aging , vol.23 , pp. 1009-1016
    • Gandy, S.1
  • 13
    • 0031824782 scopus 로고    scopus 로고
    • Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
    • Geula C., Wu C.K., Saroff D., Lorenzo A., Yuan M., Yankner B.A. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4:1998;827-831.
    • (1998) Nat. Med. , vol.4 , pp. 827-831
    • Geula, C.1    Wu, C.K.2    Saroff, D.3    Lorenzo, A.4    Yuan, M.5    Yankner, B.A.6
  • 14
    • 0034082560 scopus 로고    scopus 로고
    • Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease
    • Giacobini E. Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 14:2000;S3-S10.
    • (2000) Alzheimer Dis. Assoc. Disord. , vol.14
    • Giacobini, E.1
  • 15
    • 0037248301 scopus 로고    scopus 로고
    • Alzheimer disease therapy: Can the amyloid cascade be halted?
    • Golde T.E. Alzheimer disease therapy. can the amyloid cascade be halted? J. Clin. Invest. 111:2003;11-18.
    • (2003) J. Clin. Invest. , vol.111 , pp. 11-18
    • Golde, T.E.1
  • 16
    • 0035943436 scopus 로고    scopus 로고
    • Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
    • Götz J., Chen F., vanDorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science. 293:2001;1491-1495.
    • (2001) Science , vol.293 , pp. 1491-1495
    • Götz, J.1    Chen, F.2    VanDorpe, J.3    Nitsch, R.M.4
  • 17
    • 0029789379 scopus 로고    scopus 로고
    • Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
    • Growdon J.H., Locascio J.J., Corkin S., Gomez-Isla T., Hyman B.T. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 47:1996;444-448.
    • (1996) Neurology , vol.47 , pp. 444-448
    • Growdon, J.H.1    Locascio, J.J.2    Corkin, S.3    Gomez-Isla, T.4    Hyman, B.T.5
  • 18
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    • Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease. progress and problems on the road to therapeutics Science. 297:2002;353-356.
    • (2002) Science , vol.297 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 20
    • 0031914718 scopus 로고    scopus 로고
    • Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes
    • Holcomb L., Gorson M.N., McGowan F., Yu X., Benkovic S., Janzen P., Wright K., Saad I., Mueller R., Morgan D.et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes. Nat. Med. 4:1998;97-100.
    • (1998) Nat. Med. , vol.4 , pp. 97-100
    • Holcomb, L.1    Gorson, M.N.2    McGowan, F.3    Yu, X.4    Benkovic, S.5    Janzen, P.6    Wright, K.7    Saad, I.8    Mueller, R.9    Morgan, D.10
  • 21
    • 0036376917 scopus 로고    scopus 로고
    • Disordered proteins in dementia
    • Ingelsson M., Hyman B.T. Disordered proteins in dementia. Ann. Med. 34:2002;259-271.
    • (2002) Ann. Med. , vol.34 , pp. 259-271
    • Ingelsson, M.1    Hyman, B.T.2
  • 23
    • 0028114429 scopus 로고
    • The Clinician Interview-Based Impression (CIBI): A clinician's global change rating scale in Alzheimer's disease
    • Knopman D.S., Knapp M.J., Gracon S.I., Davis C.S. The Clinician Interview-Based Impression (CIBI). a clinician's global change rating scale in Alzheimer's disease Neurology. 44:1994;2315-2321.
    • (1994) Neurology , vol.44 , pp. 2315-2321
    • Knopman, D.S.1    Knapp, M.J.2    Gracon, S.I.3    Davis, C.S.4
  • 25
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease. report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology. 34:1984;939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3    Katzman, R.4    Price, D.5    Stadlan, E.M.6
  • 27
    • 0027425211 scopus 로고
    • The Clinical Dementia Rating (CDR): Current version and scoring rules
    • Morris J.C. The Clinical Dementia Rating (CDR). current version and scoring rules Neurology. 43:1993;2412-2414.
    • (1993) Neurology , vol.43 , pp. 2412-2414
    • Morris, J.C.1
  • 28
    • 0024453856 scopus 로고
    • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease
    • Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1989;1159-1165.
    • (1989) Neurology , vol.39 , pp. 1159-1165
    • Morris, J.C.1    Heyman, A.2    Mohs, R.C.3    Hughes, J.P.4    Van Belle, G.5    Fillenbaum, G.6    Mellits, E.D.7    Clark, C.8
  • 29
    • 0027749448 scopus 로고
    • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of propable Alzheimer's disease
    • Morris J.C., Edland S., Clark C., Galasko D., Koss E., Mohs R., van Belle G., Fillenbaum G., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of propable Alzheimer's disease. Neurology. 43:1993;2457-2465.
    • (1993) Neurology , vol.43 , pp. 2457-2465
    • Morris, J.C.1    Edland, S.2    Clark, C.3    Galasko, D.4    Koss, E.5    Mohs, R.6    Van Belle, G.7    Fillenbaum, G.8    Heyman, A.9
  • 30
    • 0038117796 scopus 로고    scopus 로고
    • Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
    • Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P., Buxbaum J.D. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 283:2000;1571-1577.
    • (2000) JAMA , vol.283 , pp. 1571-1577
    • Naslund, J.1    Haroutunian, V.2    Mohs, R.3    Davis, K.L.4    Davies, P.5    Greengard, P.6    Buxbaum, J.D.7
  • 31
    • 0030681215 scopus 로고    scopus 로고
    • Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease
    • The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol. Aging. 18:1997;S1-S2.
    • (1997) Neurobiol. Aging , vol.18
  • 32
    • 0037393454 scopus 로고    scopus 로고
    • Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: A case report
    • Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide. a case report Nat. Med. 9:2003;448-452.
    • (2003) Nat. Med. , vol.9 , pp. 448-452
    • Nicoll, J.A.1    Wilkinson, D.2    Holmes, C.3    Steart, P.4    Markham, H.5    Weller, R.O.6
  • 34
    • 0021520020 scopus 로고
    • A new rating scale for Alzheimer's disease
    • Rosen W.G., Mohs R.C., Davis K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry. 141:1984;1356-1364.
    • (1984) Am. J. Psychiatry , vol.141 , pp. 1356-1364
    • Rosen, W.G.1    Mohs, R.C.2    Davis, K.L.3
  • 35
    • 0036780877 scopus 로고    scopus 로고
    • Amyloid-β immunotherapy for Alzheimer's disease: The end of the beginning
    • Schenk D. Amyloid-β immunotherapy for Alzheimer's disease. the end of the beginning Nat. Rev. Neurosci. 3:2002;824-828.
    • (2002) Nat. Rev. Neurosci. , vol.3 , pp. 824-828
    • Schenk, D.1
  • 37
    • 0035066332 scopus 로고    scopus 로고
    • Alzheimer's disease: Genes, proteins, and therapy
    • Selkoe D.J. Alzheimer's disease. genes, proteins, and therapy Physiol. Rev. 81:2001;741-766.
    • (2001) Physiol. Rev. , vol.81 , pp. 741-766
    • Selkoe, D.J.1
  • 38
    • 0036855661 scopus 로고    scopus 로고
    • Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease
    • Selkoe D.J. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J. Clin. Invest. 110:2002;1375-1381.
    • (2002) J. Clin. Invest. , vol.110 , pp. 1375-1381
    • Selkoe, D.J.1
  • 40
    • 0036548070 scopus 로고    scopus 로고
    • γ-secretase, notch, Aβ and Alzheimer's disease: Where do the presenilins fit in?
    • Sisodia S.S., St. George-Hyslop P.H. γ-secretase, notch, Aβ and Alzheimer's disease. where do the presenilins fit in? Nat. Rev. Neurosci. 3:2002;281-290.
    • (2002) Nat. Rev. Neurosci. , vol.3 , pp. 281-290
    • Sisodia, S.S.1    St. George-Hyslop, P.H.2
  • 41
    • 0034568802 scopus 로고    scopus 로고
    • Intramembraneous proteolysis by presenilins
    • Steiner H., Haass C. Intramembraneous proteolysis by presenilins. Nat. Rev. Mol. Cell Biol. 1:2000;217-224.
    • (2000) Nat. Rev. Mol. Cell Biol. , vol.1 , pp. 217-224
    • Steiner, H.1    Haass, C.2
  • 42
    • 0035477333 scopus 로고    scopus 로고
    • The cell biology of Alzheimer's disease: Uncovering the secrets of secretases
    • Walter J., Kaether C., Steiner H., Haass C. The cell biology of Alzheimer's disease. uncovering the secrets of secretases Curr. Opin. Neurobiol. 11:2001;585-590.
    • (2001) Curr. Opin. Neurobiol. , vol.11 , pp. 585-590
    • Walter, J.1    Kaether, C.2    Steiner, H.3    Haass, C.4
  • 44
    • 0037180823 scopus 로고    scopus 로고
    • Inflammation and therapeutic vaccination in CNS diseases
    • Weiner H.L., Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature. 420:2002;879-884.
    • (2002) Nature , vol.420 , pp. 879-884
    • Weiner, H.L.1    Selkoe, D.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.